You are here

buntanetap

Annovis Bio doses first subject in Phase III Parkinson’s trial

Clinical Trials Arena

Thu, 08/25/22 - 10:49 am

clinical trials

Parkinson's Disease

Intercept, Annovis and Biohaven Advance Late Phase Trials

BioSpace

Mon, 07/11/22 - 12:00 am

Intercept Pharma NASH

Parkinson's Disease

taldefgrobep alfa